Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PIRARUBICIN: 1,348 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,348
Total FAERS Reports
143 (10.6%)
Deaths Reported
628
Hospitalizations
1,348
As Primary/Secondary Suspect
153
Life-Threatening
15
Disabilities

Active Ingredient: PIRARUBICIN HYDROCHLORIDE ·

First Report: 199708 · Latest Report: 20250911

What Are the Most Common PIRARUBICIN Side Effects?

#1 Most Reported
Myelosuppression
408 reports (30.3%)
#2 Most Reported
White blood cell count decreased
207 reports (15.4%)
#3 Most Reported
Neutrophil count decreased
145 reports (10.8%)

All PIRARUBICIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myelosuppression 408 30.3% 5 260
White blood cell count decreased 207 15.4% 9 114
Neutrophil count decreased 145 10.8% 3 90
Bone marrow failure 127 9.4% 14 55
Nausea 111 8.2% 2 68
Vomiting 104 7.7% 2 70
Gastrointestinal disorder 58 4.3% 1 39
Leukopenia 55 4.1% 0 21
Pyrexia 55 4.1% 4 36
Neutropenia 54 4.0% 13 18
Febrile neutropenia 53 3.9% 13 16
Decreased appetite 50 3.7% 7 20
Platelet count decreased 43 3.2% 6 21
Anaemia 42 3.1% 6 13
Hepatic function abnormal 41 3.0% 3 11
Agranulocytosis 39 2.9% 3 22
Drug ineffective 39 2.9% 16 8
Granulocytopenia 37 2.7% 0 25
Off label use 37 2.7% 10 16
Asthenia 35 2.6% 4 20

Who Reports PIRARUBICIN Side Effects? Age & Gender Data

Gender: 71.7% female, 28.3% male. Average age: 50.4 years. Most reports from: CN. View detailed demographics →

Is PIRARUBICIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 1 0 1
2003 1 0 1
2004 1 0 0
2008 2 2 2
2009 1 1 0
2011 4 2 0
2012 5 2 2
2013 1 0 1
2014 9 2 4
2015 18 5 10
2016 14 2 2
2017 11 1 4
2018 20 4 11
2019 70 0 47
2020 87 0 49
2021 121 0 77
2022 163 3 109
2023 137 1 88
2024 128 0 74
2025 67 0 39

View full timeline →

What Is PIRARUBICIN Used For?

IndicationReports
Breast cancer female 271
Diffuse large b-cell lymphoma 175
Chemotherapy 135
Breast cancer 82
Lymphoma 68
Invasive ductal breast carcinoma 56
Acute lymphocytic leukaemia 51
Non-hodgkin's lymphoma 40
Neoplasm 38
B-cell lymphoma 36

PIRARUBICIN vs Alternatives: Which Is Safer?

PIRARUBICIN vs PIRFENIDONE PIRARUBICIN vs PIRIBEDIL PIRARUBICIN vs PIRITRAMIDE PIRARUBICIN vs PIROXICAM PIRARUBICIN vs PIRTOBRUTINIB PIRARUBICIN vs PIT VIPER IMMUNE GLOBULIN ANTIVENIN PIRARUBICIN vs PITAVASTATIN PIRARUBICIN vs PITOLISANT PIRARUBICIN vs PIXANTRONE PIRARUBICIN vs PIZOTYLINE

Official FDA Label for PIRARUBICIN

Official prescribing information from the FDA-approved drug label.